Biomedical Engineering Reference
In-Depth Information
[436] Egleton RD, Davis TP. Bioavailability and transport of peptides and peptide drugs into
the brain. Peptides 1997;18:1431-9.
[437] Morizono K, Bristol G, Xie Y, Pun Kung S, Irvin S, Chen Y. Antibody-directed target-
ing of retroviral vectors via cell surface antigens. J Virol 2001;75:8016-20.
[438] Mastrobattista E, Koning GA, van Bloois L, Filipe ACS, Jiskoot W, Gert S. Functional
characterization of an endosomedisruptive peptide and its application in cytosolic deliv-
ery of immunoliposome-entrapped proteins. J Biol Chem 2002;277:27135-43.
[439] Lackey CA, Murthy N, Press OW, Hoffman AS, Stayton PS. A biomimetic pH respon-
sive polymer directs endosomal release and intracellular delivery of an endocytosed
antibody complex. Bioconjug Chem 2002;13:996-1001.
[440] Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidylethanolamine in cat-
ionic liposome mediated gene transfer. Biochim Biophys Acta 1995;1235:289-95.
[441] Scheule RK St., George JA, Bagley RG, Marshall J, Kaplan JM, Akita GY, et al. Basis
of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mam-
malian lung. Hum Gene Ther 1997;8:689-707.
[442] Filion MC, Phillips NC. Toxicity and immunomodulatory activity of liposomal vectors
formulated with cationic lipids toward immune effector cells. Biochim Biophys Acta
1997;1329:345-56.
[443] Tang FX, Hughes JA. Use of dithiodiglycolic acid as a tether for cationic lipids
decreases the cytotoxicity and increases transgene expression of plasmid DNA in vitro .
Bioconjug Chem 1999;10:791-6.
[444] Bidwell GL III, Raucher D. Cell penetrating elastin-like polypeptides for therapeutic
peptide delivery. Adv Drug Delivery Rev 2010;doi:10.1016/j.addr.2010.05.003.
[445] Lundin P, Johansson H, Guterstam P, Holm T, Hansen M, Langel U, et al.
Distinct uptake routes of cell-penetrating peptide conjugates. Bioconjug Chem
2008;19:2535-42.
[446] Reyes CM, Nifosi R, Frankel AD, Kollman PA. Molecular dynamics and binding speci-
ficity analysis of the bovine immunodeficiency virus BIV Tat-TAR complex. Biophys J
2001;80:2833-42.
[447] Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency
virus. Cell 1988;55:1189-93.
[448] Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized
human immunodeficiency virus tat trans-activator protein. Cell 1988;55:1179-88.
[449] Schwarze SR, Dowdy SF. In vivo protein transduction: intracellular delivery of biologi-
cally active proteins, compounds and DNA. Trends Pharmacol Sci 2000;21:45-8.
[450] Joliot A, Pernelle C, Deagostini-Bazin H, Prochiantz A. Antennapedia homeobox pep-
tide regulates neural morphogenesis. Proc Natl Acad Sci USA 1991;88:1864-8.
[451] Bian J, Popovic ZB, Benejam C, Kiedrowski M, Leonardo Rodriguez L, Penn MS.
Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic
cardiomyopathy. Circ Res 2007;100:1626-33.
[452] Pooga M, Hallbrink M, Zorko M, Langel U. Cell penetration by transportan. FASEB J
1998;12:67-77.
[453] Oehlke J, Scheller A, Wiesner B, Krause E, Beyermann M, Klauschenz E, et al. Cellular
uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar
compounds into the cell interior non-endocytically. Biochim Biophys Acta 1998;1414:
127-39.
[454] Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, et al. Arginine-rich pep-
tides. An abundant source of membrane-permeable peptides having potential as carriers
for intracellular protein delivery. J Biol Chem 2001;276:5836-40.
Search WWH ::




Custom Search